| Product Name | Raltegravir - Impurity E |
| Product Code | DA-R009-f |
| Chemical name | N-Benzyl-5-hydroxy-1-methyl-2-[2-(5-methyl-1,3,4-oxadiazole-2-carboxamido)propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide |
| Synonyms | 4-Defluoro Raltegravir; N-Benzyl-5-hydroxy-1-methyl-2-[2-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]propan-2-yl]-6-oxo-1,6-dihydropyrimidine-4-carboxamide; 1,6-Dihydro-5-hydroxy-1-methyl-2-[1-methyl-1-[[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino]ethyl]-6-oxo-N-(phenylmethyl)-4-pyrimidinecarboxamide; N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide; Raltegravir Related Compound E (USP); |
| Impurity | NA |
| CAS Number | 1193687-87-4 |
| Alternate CAS # | NA |
| Molecular form | C20H22N6O5 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 426.43 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | amines,aromatics,heterocycles,pharmaceutical standards,intermediates,Fine Chemicals |
| Boiling Point | NA |
| Applications | NA |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
